Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia.
Saved in:
| Title: | Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia. |
|---|---|
| Authors: | AlRuthia, Yazed1,2 (AUTHOR) Yazeed@ksu.edu.sa, Alfakhri, Almaha H.3 (AUTHOR), Alharbi, Ibtisam4 (AUTHOR), Alghamdi, Fadi Ali5 (AUTHOR), Alanazi, Miteb A.3 (AUTHOR), Alrabiah, Abdullah Abdulrahman6 (AUTHOR), Alsouan, Anwar Abdulrazzag6 (AUTHOR), Alshaikh, Abdulrahman Abdullah6 (AUTHOR), Almasaoud, Majed Ali6 (AUTHOR) |
| Source: | Cost Effectiveness & Resource Allocation. 12/9/2023, Vol. 21 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
